Press Release 2021


Sabinsa Reaches Intellectual Property Milestone with over 300 Patents Granted

July 12, 2021

Sabinsa’s intellectual property portfolio now includes 308 separate patents granted across the world. The most recent patents…


Sabinsa Cosmeceutical Ingredients COSMOS Approved: Cococin™, Saberry®, and Nigellin® Amber

June 28, 2021

Sabinsa has successfully completed the audit for several of its natural cosmetic ingredients as conforming to COSMOS standards…


Research Published on Sabinsa's Curcumin C3 Complex®/BioPerine® Combination as Adjuvant Therapy in COVID-19 Patients

June 24, 2021

Sabinsa's flagship combination product, Curcumin C3 Complex® with BioPerine® (525mg/2.5 mg twice a day, 14 days), was used as adjuvant therapy for COVID-19 in a double-blind…


Court Orders Prakruti to Pay over $1 Million in Fees and Costs to Sabinsa as a Sanction For Discovery Abuses in Litigation

June 08, 2021

Sami-Sabinsa Group Limited, the world leader in Curcumin for the dietary supplements industry, has been awarded more than $1 Million in attorney’s fees and costs against Prakruti Products…


Sabinsa Founder Dr. Muhammed Majeed Named Father of Indian Nutraceuticals Industry by ASSOCHAM

June 01, 2021

Dr. Muhammed Majeed, founder of the Sami-Sabinsa Group, was named the Father of Indian Nutraceuticals Industry with an honorary award presented on the occasion of ASSOCHAM…


New Research Published on Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient

January 25, 2021

New research has recently been published that builds upon evidence from a previous trial investigating the potential of Sabinsa’s Curcumin C3 Reduct®…


Sabinsa Top Scientist Gives Presentation to U.S. FDA

January 21, 2021

Dr. Kalyanam Nagabhushanam, President (R&D), Sabinsa Corporation presented, at the invitation of FDA…